An antibiotic used to treat infective diarrhea could be an effective drug for a type of inflammatory bowel disease, a new ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

On Jan. 30, the U.S. Food and Drug Administration (FDA) approved a new drug called suzetrigine to treat moderate-to-severe pain. The prescription pills, sold under the brand name Journavx and made by ...

Since Viagra is a brand-name medication, the price of Viagra is very high and may not currently fit within your budget. But a generic version (and the active ingredient) of this popular medication ...

Xarelto is a brand name of the drug rivaroxaban. Medicare covers the cost of prescription medications, including Xarelto, under certain conditions. A person must be enrolled in a Medicare Part D ...

For Sesame Care’s ED treatments, the company offers Tadalafil — the generic version of the brand name Cialis — and sildenafil, the generic version of the brand Viagra. The company states ...

Patrick Mahomes and the Chiefs earned a first-round bye in the 2025 playoffs after finishing as the No. 1 seed in the AFC. Even though the team was off, the Kansas City quarterback was certainly busy.

In recent years, we've seen some unusual baby names spiral in popularity, whether that's a name after a season or one that is a little trickier to pronounce - but this year, traditional names are ...

She also served as the lead attorney for Boston’s Organized Crime & Drug Enforcement Task Force since 2013. She has prosecuted a number of high-profile drug trafficking and sex trafficking crimes.

Some of China’s senior doctors are raising concern over the quality of domestic generic medicines that have largely replaced western brand-name drugs at hospitals, amid a rare public backlash ...